Cargando…

Application of herbs and active ingredients ameliorate non-alcoholic fatty liver disease under the guidance of traditional Chinese medicine

Non-alcoholic fatty liver disease (NAFLD) is a global health problem, and its prevalence has been on the rise in recent years. Traditional Chinese Medicine (TCM) contains a wealth of therapeutic resources and has been in use for thousands of years regarding the prevention of liver disease and has be...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Zhijia, Zhang, Jinghao, You, Liping, Wang, Tao, Wang, Kaixia, Wang, Lingtai, Kong, Xiaoni, Gao, Yueqiu, Sun, Xuehua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9530134/ https://www.ncbi.nlm.nih.gov/pubmed/36204095 http://dx.doi.org/10.3389/fendo.2022.1000727

Ejemplares similares

Comprehensive analysis of nine m7G-related lncRNAs as prognosis factors in tumor immune microenvironment of hepatocellular carcinoma and experimental validation
por: Wang, Tao, et al.
Publicado: (2022)

Current Perspective of Traditional Chinese Medicines and Active Ingredients in the Therapy of Hepatocellular Carcinoma
por: Li, Yuyao, et al.
Publicado: (2022)

Electroacupuncture Pretreatment at Zusanli (ST36) Ameliorates Hepatic Ischemia/Reperfusion Injury in Mice by Reducing Oxidative Stress via Activating Vagus Nerve-Dependent Nrf2 Pathway
por: Jiang, Haochen, et al.
Publicado: (2023)

Seabuckthorn polysaccharide combined with astragalus polysaccharide ameliorate alcoholic fatty liver by regulating intestinal flora
por: Liu, Jiayue, et al.
Publicado: (2022)

Systematic elucidation of the mechanism of Jingyin granule in the treatment of Novel Coronavirus (COVID-19) Pneumonia via Network Pharmacology
por: Wang, Bingrui, et al.
Publicado: (2021)

Quantitative proteomics reveals Polygonum perfoliatum L. ameliorates hepatic steatosis by promoting PPARs/CPT1A/CPT2-mediated fatty acid β-oxidation
por: Liu, Guanjie, et al.
Publicado: (2023)

Qushi Huayu decoction ameliorates non-alcoholic fatty liver disease in rats by modulating gut microbiota and serum lipids
por: Ni, Yiming, et al.
Publicado: (2023)

Deficiency of DJ-1 Ameliorates Liver Fibrosis through Inhibition of Hepatic ROS Production and Inflammation
por: Yu, Yingxue, et al.
Publicado: (2016)

“Liver–gut” axis: A target of traditional Chinese medicine for the treatment of non-alcoholic fatty liver disease
por: Guo, Kangxiao, et al.
Publicado: (2022)

Antidepressant Active Ingredients From Chinese Traditional Herb Panax Notoginseng: A Pharmacological Mechanism Review
por: Li, Yanwei, et al.
Publicado: (2022)

Chinese Medicinal Herbs Targeting the Gut–Liver Axis and Adipose Tissue–Liver Axis for Non-Alcoholic Fatty Liver Disease Treatments: The Ancient Wisdom and Modern Science
por: Zhang, Shuwei, et al.
Publicado: (2020)

Analysis of N6-Methyladenosine Methylation Modification in Fructose-Induced Non-Alcoholic Fatty Liver Disease
por: Luo, Yunchen, et al.
Publicado: (2021)

Nobiletin suppresses cholangiocarcinoma proliferation via inhibiting GSK3β
por: You, Liping, et al.
Publicado: (2022)

Quantitative proteomics of HFD-induced fatty liver uncovers novel transcription factors of lipid metabolism
por: Zhi, Shang, et al.
Publicado: (2022)

PARK7 deficiency inhibits fatty acid β‐oxidation via PTEN to delay liver regeneration after hepatectomy
por: Qu, Xiaoye, et al.
Publicado: (2022)

Endotoxins and Non-Alcoholic Fatty Liver Disease
por: Kessoku, Takaomi, et al.
Publicado: (2021)

A herb mixture to ameliorate non-alcoholic fatty liver in rats fed a high-fat diet
por: Ha, Sang Keun, et al.
Publicado: (2023)

Herb-Induced Liver Injury: Phylogenetic Relationship, Structure-Toxicity Relationship, and Herb-Ingredient Network Analysis
por: He, Shuaibing, et al.
Publicado: (2019)

Comparison between traditional and new obesity measurement index for screening metabolic associated fatty liver disease
por: Wang, Hongyan, et al.
Publicado: (2023)

Effects of sitagliptin on intrahepatic lipid content in patients with non-alcoholic fatty liver disease
por: Wang, Xingchun, et al.
Publicado: (2022)

Gut Dysfunction and Non-alcoholic Fatty Liver Disease
por: Grabherr, Felix, et al.
Publicado: (2019)

Antibiotics enhancing drug-induced liver injury assessed for causality using Roussel Uclaf Causality Assessment Method: Emerging role of gut microbiota dysbiosis
por: Fu, Lihong, et al.
Publicado: (2022)

Liver-bone crosstalk in non-alcoholic fatty liver disease: Clinical implications and underlying pathophysiology
por: Zhao, Jiahui, et al.
Publicado: (2023)

Obesity, non-alcoholic fatty liver disease and hepatocellular carcinoma: current status and therapeutic targets
por: Chen, Yinshuang, et al.
Publicado: (2023)

Herbs as an Active Ingredient in Sport: Availability and Information on the Internet
por: Garcia, Juan F., et al.
Publicado: (2022)

Using hyperhomocysteinemia and body composition to predict the risk of non-alcoholic fatty liver disease in healthcare workers
por: Hao, Xiaoyan, et al.
Publicado: (2023)

Oxidation-Specific Epitopes in Non-Alcoholic Fatty Liver Disease
por: Hendrikx, Tim, et al.
Publicado: (2020)

Determinants of hyperglucagonemia in pediatric non-alcoholic fatty liver disease
por: Maruszczak, Katharina, et al.
Publicado: (2022)

Advancements in the treatment of non-alcoholic fatty liver disease (NAFLD)
por: Rong, Li, et al.
Publicado: (2023)

Inhibiting Ceramide Synthesis Attenuates Hepatic Steatosis and Fibrosis in Rats With Non-alcoholic Fatty Liver Disease
por: Jiang, Meng, et al.
Publicado: (2019)

Bufalin stimulates antitumor immune response by driving tumor-infiltrating macrophage toward M1 phenotype in hepatocellular carcinoma
por: Yu, Zhuo, et al.
Publicado: (2022)

Non-Alcoholic Fatty Liver Disease (NAFLD) Is an Independent Risk Factor for Developing New-Onset Diabetes After Acute Pancreatitis: A Multicenter Retrospective Cohort Study in Chinese Population
por: Lv, Yingqi, et al.
Publicado: (2022)

The Role of Lipophagy in the Development and Treatment of Non-Alcoholic Fatty Liver Disease
por: Grefhorst, Aldo, et al.
Publicado: (2021)

Autonomic Imbalance Increases the Risk for Non-alcoholic Fatty Liver Disease
por: Jung, Inha, et al.
Publicado: (2021)

Comprehensive analysis of endoplasmic reticulum-related and secretome gene expression profiles in the progression of non-alcoholic fatty liver disease
por: Gao, Rong, et al.
Publicado: (2022)

Gynostemma pentaphyllum polysaccharides ameliorate non-alcoholic steatohepatitis in mice associated with gut microbiota and the TLR2/NLRP3 pathway
por: Yue, Si-Ran, et al.
Publicado: (2022)

Association between the atherogenic index of plasma and new-onset non-alcoholic fatty liver disease in non-obese participants
por: Li, Kemin, et al.
Publicado: (2022)

Network Understanding of Herb Medicine via Rapid Identification of Ingredient-Target Interactions
por: Zhang, Hai-Ping, et al.
Publicado: (2014)

Non-alcoholic Fatty Liver Disease Is Associated With Aortic Calcification: A Cohort Study With Propensity Score Matching
por: Zhu, Rong-Rong, et al.
Publicado: (2022)

Thyroid Function and the Risk of Non-Alcoholic Fatty Liver Disease in Morbid Obesity
por: Borges-Canha, Marta, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_bcl1lal83vrg2vo68mlu0vd88k